4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cardiol Therapeutics Inc. (CRDL) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Oakville, Canada with about 18 employees. Its market capitalization is roughly $257 million. In the fiscal year ended 2025-12-31, CRDL reported C$0M in revenue and (C$34M) in net income.
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | C$0M | C$0M | C$0M | C$0M | — |
| Operating Income (EBIT) | (C$34M) | (C$40M) | (C$30M) | (C$41M) | — |
| Net Income | (C$34M) | (C$37M) | (C$28M) | (C$31M) | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | C$0M | C$0M | C$0M | C$0M | C$0M | — | — |
| Operating Income (EBIT) | (C$8M) | (C$10M) | (C$8M) | (C$10M) | (C$8M) | — | — |
| Net Income | (C$6M) | (C$11M) | (C$7M) | (C$10M) | (C$8M) | — | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | C$24M | C$32M | C$37M | C$62M | — |
| Total Liabilities | C$6M | C$7M | C$8M | C$10M | — |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CRDL viewer.
About TickerBase · Data methodology & sources · Privacy · Terms